发明名称 ERYTHROPOIETIN EXPRESSION PROMOTER
摘要 The present invention provides an erythropoietin expression-enhancing agent that can cancel the suppression of erythropoietin production or promote erythropoietin production, and a therapeutic or preventive drug for anemia, a liver function-improving agent, an ischemic injury-improving agent, a renal protective agent, and an insulin secretagogue comprising the erythropoietin expression-enhancing agent. The erythropoietin expression-enhancing agent of the present invention comprises one or more compounds selected from the group consisting of compounds represented by the following general formulas (I), (II), and (III) and pharmaceutically acceptable salts thereof when R 3 is OH.
申请公布号 EP2923700(A1) 申请公布日期 2015.09.30
申请号 EP20130857636 申请日期 2013.11.25
申请人 TOHOKU UNIVERSITY;KAKE EDUCATIONAL INSTITUTION;KANAGAWA PREFECTURAL HOSPITAL ORGANISATION KANAGAWA CHILDREN'S MEDICAL CENTER 发明人 ABE, TAKAAKI;TOMINAGA, TEIJI;HAYASHI, KENICHIRO;OSAKA, HITOSHI
分类号 A61K31/405;A61P1/16;A61P3/10;A61P5/50;A61P7/06;A61P9/10;A61P13/12;C07D209/18;C07D401/06 主分类号 A61K31/405
代理机构 代理人
主权项
地址